This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Yao, J. D.C. Articles by Karchmer, A. W. Search for Related Content PubMed PubMed Citation Articles by Yao, J. D.C. Articles by Karchmer, A. W. Social Bookmarking                         What's this?

Vancomycin Stability in Heparin and Total Parenteral Nutrition Solutions: Novel Approach to Therapy of Central Venous Catheter-Related Infections

Division of Infectious Diseases, Department of Medicine, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts, Division of Infectious Diseases, E5, Calgary General Hospital, 841 Center Ave E., Calgary, Alberta, Canada T2E 0A1

Charles F. Arkin, MD

Department of Pathology, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts

Adolf W. Karchmer, MD

Division of Infectious Diseases, Department of Medicine, New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts

To facilitate therapy of central venous catheter-related Gram-positive bacterial infection in patients who require total parenteral nutrition (TPN) therapy, we studied the stability of vancomycin in a commonly used TPN solution (V-TPN) at final concentrations of 0.5 mg/mL and 1.0 mg/mL and in heparin (100 U/mL in 0.9% NaCl) at 25 µg/mL (V-H). Vancomycin concentrations in V-TPN and V-H after storage at 4°C over 35 and 14 days, respectively, were stable (within 10% of the prestorage vancomycin concentration). After 14 days at 4°C heparin activity in V-H solution was 100 ± 4% of that noted initially. Vancomycin remained stable (100 ± 6% of the original vancomycin concentration) when the previously refrigerated V-TPN was held for an additional 24 hours at 22°C. When the previously refrigerated V-H was held for an additional 24 hours at 37°C, vancomycin concentrations decreased to 78 ± 9% of the baseline concentrations (p < .001). The stability of vancomycin in this TPN solution allows the daily dose of vancomycin to be mixed with the solution and then infused over 10 hours. As shown with pharmacokinetic modeling, this form of therapy will achieve serum vancomycin concentrations within the therapeutic range throughout a 24-hour period. The relative stability of vancomycin in a heparin line-flush solution allows vancomycin concentration in the lumen of the catheter to be maintained at 15 µg/mL during the interval between catheter flushing and the subsequent TPN infusion. A simplified method of administering vancomycin to patients receiving concurrent TPN is possible. (Journal of Parenteral and Enteral Nutrition 16:268-274, 1992)

Journal of Parenteral and Enteral Nutrition, Vol. 16, No. 3, 268-274 (1992)
DOI: 10.1177/0148607192016003268


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				O Plan, G Cambonie, E Barbotte, P Meyer, C Devine, C Milesi, O Pidoux, M Badr, and J C Picaud Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F418 - F421. [Abstract] [Full Text] [PDF]

				B. Jurewitsch, T. Lee, J. Park, and K. Jeejeebhoy Taurolidine 2% as an Antimicrobial Lock Solution for Prevention of Recurrent Catheter-Related Bloodstream Infections JPEN J Parenter Enteral Nutr, July 1, 1998; 22(4): 242 - 244. [Abstract] [PDF]

				C. A. Hammett-Stabler and T. Johns Laboratory guidelines for monitoring of antimicrobial drugs Clin. Chem., May 1, 1998; 44(5): 1129 - 1140. [Abstract] [Full Text] [PDF]

				S. J.D. O'Keefe, J. U. Burnes, and R. L. Thompson Recurrent Sepsis in Home Parenteral Nutrition Patients: An Analysis of Risk Factors JPEN J Parenter Enteral Nutr, May 1, 1994; 18(3): 256 - 263. [Abstract] [PDF]